Navigation Links
Palatin Technologies, Inc. To Report First Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on November 14, 2013
Date:11/11/2013

CRANBURY, N.J., Nov. 11, 2013 /PRNewswire/ -- Palatin Technologies, Inc. (NYSE MKT: PTN) will announce its first quarter, fiscal year 2014 operating results on Thursday, November 14, 2013 before the open of the U.S. financial markets.

Palatin will also conduct a conference call and live audio webcast hosted by its executive management team on November 14, 2013 at 10:00 a.m. ET. The conference call will include a review on the company's operating results and an update on programs under development.Schedule for the Operating Results Press Release, Conference Call / WebcastQ1 Fiscal Year 2014 Financial Results Press Release11/14/2013 at 7:30 a.m. ET Q1 Fiscal Year 2014 Conference Call-Live 

11/14/2013 at 10:00 a.m. ET Domestic Dial-In Number 

1-888-280-4443International Dial-In Number1-719-457-2601Passcode 

3153901Q1 Fiscal Year 2014 Conference Call-Replay

11/14/2013-11/21/2013 Domestic Dial-In Number1-888-203-1112International Dial-In Number

1-719-457-0820Passcode3153901Webcast Live and Replay Accesshttp://www.palatin.com  The webcast and replay can be accessed by logging on to the "Investor/Media Center-Webcasts" section of Palatin's website at http://www.palatin.com About Palatin Technologies, Inc.
Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin's strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information, please visit http://www.palatin.com or follow us on Twitter at http://twitter.com/PalatinTech.


'/>"/>
SOURCE Palatin Technologies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Palatin Technologies Reports Successful Completion Of Device Bioequivalence Trial
2. Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2013 Results
3. Palatin Technologies, Inc. To Report Fiscal Year 2013 Fourth Quarter Results
4. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides
5. Palatin Technologies Announces Last Patient Completed Treatment In Phase 2B Bremelanotide Female Sexual Dysfunction Trial
6. Study Assesses New Tools, Technologies, and Approaches for Understanding and Communicating with Consumers
7. Emerging Drug Delivery Technologies, Profiles of Start-ups and Early-Stage Companies
8. Global Laboratory Analytical Instrument Market 2012-2016: Agilent Technologies, Bruker Corp. and Thermo Fisher Scientific Inc. Dominate the Market
9. Technical Scrutiny: Thermo Fisher, Agilent Technologies, Laboratory Corp. of America, and PerkinElmer
10. FDA Approvals, Dividends, New Technologies, and Solid Margins Increase Shareholder Value - Research Report on Abbott, Baxter, CareFusion, Haemonetics, and CR Bard
11. Therapeutic Drug Monitoring - Technologies, Markets, and Companies - 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... The Institute for In Vitro Sciences (IIVS), ... of a VITROCELL® inhalation exposure system thanks to a ... device, which is designed to replace animals in inhalation ... to airborne test materials in an environment that mimics ... for testing combustible tobacco products, as well as next ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston ... and unparalleled access to global decision makers and innovative ... 800+ life science leaders during two impactful days. BioPharm ... provides delegates with additional networking opportunities with 4,500+ life ...
(Date:7/6/2017)... , July 6, 2017 ThriveRx, the nutrition division of Diplomat ... families to thrive on nutrition support. To celebrate its anniversary, ... site has a fresh new look with improved organization to create the ... ... "We,ve ...
Breaking Medicine Technology:
(Date:7/26/2017)... ... July 26, 2017 , ... ... Engineering (ISPE) will host its 2017 Process Validation and Process Validation ... offer comprehensive solutions to process validation lifecycle challenges faced by process validation ...
(Date:7/26/2017)... ... 2017 , ... A global center of excellence specializing in ... of the art center will provide advanced surgical care (heart surgery), management of ... patients longer lives. , North American Veterinary Heart Center, the “Heart Center,” will ...
(Date:7/26/2017)... , ... July 26, 2017 , ... ... innovative specialty pharmacies, has released an updated version of the HCV Treatment Path ... for treating chronic hepatitis C virus (HCV) infection. All of the latest HCV ...
(Date:7/25/2017)... ... 25, 2017 , ... Creative Pharmacist and ... the Pharmacist eCare Plan to Computer-Rx pharmacies through the STRAND platform. ... to develop the Pharmacist eCare Plan, a shared document detailing a patient’s current ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Gina Negrette, a ... more than a decade of experience in psychiatry, treating clients in diverse settings, ... eating disorders, psychotic and manic conditions, as well as those who were fighting ...
Breaking Medicine News(10 mins):